Skip to the answer

Stiripentol Uses, Dosage, Side Effects and Interactions

Brand name
Diacomit

Diacomit was the first stiripentol product the FDA approved, in August 2018. No generic is listed as capsules and oral suspension.

When will Diacomit go generic?

Stiripentol (Diacomit) is an anti-seizure medicine used with clobazam to treat seizures caused by Dravet syndrome in infants and children.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About StiripentolType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Stiripentol in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Stiripentol (Diacomit) is a specialist add-on medicine for seizures from Dravet syndrome, a rare, severe childhood epilepsy, and it is always used with clobazam. It may calm the brain through GABA-A receptors (the brain's calming signals) and slows the liver enzymes that clear clobazam, raising clobazam levels; it has been on the U.S. market since about 2018. Sleepiness is what families notice most, partly from those higher clobazam levels, along with poorer appetite and weight loss. Heavy or lasting drowsiness is the thing to watch and call about, since the clobazam dose may need lowering, and blood counts are checked before starting and every 6 months.

Key Takeaways From the HelloPharmacist Team

  • Give it with meals, two or three times a day; swallow capsules whole, and give the powder right after mixing it in water.
  • Never stop it suddenly, even if it disappoints; that can trigger more seizures or status epilepticus (a long, dangerous seizure).
  • Check with the pharmacist before any new medicine, since stiripentol changes levels of many, and phenytoin, carbamazepine or phenobarbital can weaken it.
  • Watch for new mood or behavior changes or talk of self-harm, and report them right away, as with any seizure medicine.

How we write and review this content: our editorial policy

Stiripentol by the Numbers

Strengths
4
across 2 forms
Makers and packagers
1
Earliest FDA record
2018
Rank by Medicaid prescriptions
#1,159 of 1,682 drugs
More prescriptions than 31% of the 1,682 drugs we measure
3,030 prescriptions, Q1–Q4 2025

Patient Information Guide for Stiripentol

What It’s Used For

Stiripentol is used for one specific condition.

  • Diacomit treats seizures associated with Dravet syndrome in patients taking clobazam who are 6 months or older and weigh 7 kg or more.
  • There are no clinical data supporting Diacomit as the only medicine for Dravet syndrome.

How It Works

How stiripentol works against seizures in humans is unknown. It may act directly on GABA-A receptors, which help calm brain activity.

It may also block liver enzymes (cytochrome P450), which raises the blood levels of clobazam and its active metabolite.

Drug Class

WHO drug family

  • Other antiepileptics
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)

None. The FDA’s index lists no class of any kind for Stiripentol.

The main drug class the FDA gives it. It is the class named on the drug’s label.

What It Does in the Body

Physiologic effect (PE)

None listed for Stiripentol in the FDA’s index.

From our Patient Information GuideHow stiripentol works against seizures in humans is unknown. It may act directly on GABA-A receptors, which help calm brain activity. Read How Stiripentol Works

A change it makes in how the body works.

Drug Family

WHO ATC classification
  • Other antiepileptics

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.

Dosage

Diacomit is taken by mouth in 2 or 3 divided doses a day, based on age and weight. It is taken during a meal.

  • Capsules: swallow whole with water. Don't open or break them.
  • Powder for suspension: mix in water and drink right away.
  • Missed dose: take it as soon as you can. If it's almost time for the next dose, skip it. Never double up.
  • Stopping: your doctor will lower the dose gradually.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Seizures from Dravet syndrome (taken with clobazam)

Patients 1 year and older, 10 kg and above Usual dose 25 mg/kg twice a day or 16.67 mg/kg three times a day Highest dose 3000 mg a day

Step by step

  1. 25 mg/kg twice daily or 16.67 mg/kg three times daily, by mouth in equally divided doses
  2. Total daily dose 50 mg/kg/day
Children 6 months to less than 1 year old, 7 kg and above Usual dose 25 mg/kg twice a day Highest dose 3000 mg a day

Step by step

  1. 25 mg/kg twice daily, by mouth in equally divided doses
  2. Total daily dose 50 mg/kg/day

Good to know

Dosing frequency should not exceed twice daily to limit free water administration and to avoid overexposures

Children 1 year and older, 7 kg to less than 10 kg Usual dose 25 mg/kg twice a day Highest dose 3000 mg a day

Step by step

  1. 25 mg/kg twice daily, by mouth in equally divided doses
  2. Total daily dose 50 mg/kg/day

Good to know

Dosing frequency should not exceed twice daily to avoid overexposures

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects in studies were:

Common side effects

  • Sleepiness (somnolence)
  • Decreased appetite
  • Weight loss
  • Agitation
  • Unsteady walking or balance (ataxia)
  • Low muscle tone (hypotonia)
  • Nausea
  • Tremor, slurred speech or trouble sleeping

When to get medical help

  • Call your doctor if sleepiness is heavy or lasts, especially alongside clobazam.
  • Call your doctor if your child eats much less, loses weight, or is not growing as expected.
  • Report new or worsening depression, unusual mood or behavior changes, or thoughts of self-harm right away.
  • Seek help for signs that could point to low blood counts, as advised by your doctor. Blood tests are needed before starting and then every 6 months.
  • Don't stop suddenly. Stopping too fast can increase seizures and cause status epilepticus (a prolonged, dangerous seizure).

Call your doctor about heavy sleepiness, major weight loss, mood changes, or thoughts of self-harm.

Warnings and Precautions

  • Sleepiness: more likely with clobazam, alcohol or other sedating medicines. Avoid hazardous activities until you know how it affects you.
  • Appetite and weight loss: growth in children should be monitored.
  • Low neutrophils and platelets: blood counts are checked before starting and every 6 months.
  • Stopping suddenly: can raise seizure frequency and cause status epilepticus.
  • Suicidal thoughts: anti-seizure medicines can raise this risk, so watch for mood or behavior changes.
  • PKU: the oral suspension contains phenylalanine.

Interactions

Stiripentol affects many liver enzymes, so it can change levels of other medicines.

  • Clobazam: levels rise (about 2-fold for clobazam and 5-fold for its active metabolite), so clobazam may need to be lowered.
  • Alcohol and other CNS depressants: more sleepiness.
  • Rifampin, phenytoin, phenobarbital, carbamazepine: can lower stiripentol levels.
  • Medicines such as theophylline, caffeine, sertraline, midazolam, triazolam, quinidine, diazepam, clopidogrel, methotrexate, prazosin and glyburide: doses may need adjusting.

Interactions Listed in the FDA-Approved Label

From the Stiripentol prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • What happensDIACOMIT inhibits CYP3A4 and CYP2C19 and increases plasma concentrations of clobazam and its active metabolite norclobazam, which may increase the risk of clobazam-related adverse reactions.
    What to doConsider a reduction in dosage of clobazam if adverse reactions are experienced.
  • CYP1A2 substrates For example: theophylline, caffeine
    What happensStiripentol is both an inhibitor and inducer of CYP1A2 in vitro, so drug-drug interactions are possible.
    What to doConsider dose adjustment of the substrate as clinically appropriate.
  • CYP2B6 substrates For example: sertraline, thiotepa
    What happensStiripentol is both an inhibitor and inducer of CYP2B6 in vitro, so drug-drug interactions are possible.
    What to doConsider dose adjustment of the substrate as clinically appropriate.
  • CYP3A4 substrates For example: midazolam, triazolam, quinidine
    What happensStiripentol is both an inhibitor and inducer of CYP3A4 in vitro, so drug-drug interactions are possible.
    What to doConsider dose adjustment of the substrate as clinically appropriate.
  • CYP2C8 and CYP2C19 substrates For example: diazepam, clopidogrel
    What happensPotential inhibition of enzyme activity by DIACOMIT.
    What to doConsider a reduction in dosage of the substrate if adverse reactions are experienced.
  • P-gp substrates For example: carbamazepine
    What happensPotential inhibition of transporter activity by DIACOMIT.
    What to doConsider a reduction in dosage of the substrate if adverse reactions are experienced.
  • BCRP substrates For example: methotrexate, prazosin, glyburide
    What happensPotential inhibition of transporter activity by DIACOMIT.
    What to doConsider a reduction in dosage of the substrate if adverse reactions are experienced.
  • Strong CYP1A2, CYP3A4 or CYP2C19 inducers For example: rifampin, phenytoin, phenobarbital, carbamazepine
    What happensInduction-based interactions may decrease DIACOMIT concentrations, as these enzymes all metabolize stiripentol.
    What to doConcomitant use should be avoided, or dosage adjustments should be made.
  • CNS depressants, including alcohol
    What happensConcomitant use may increase the risk of sedation and somnolence.
Read the label’s full interactions text

7 DRUG INTERACTIONS DIACOMIT increases the plasma concentration of clobazam and its metabolite through metabolic inhibition of CYP3A4 and CYP2C19. Consider dose reduction of clobazam in case of adverse reactions. Substrates of CYP2C8, CYP2C19, P-gp and BCRP may require a dose reduction. Substrates of CYP1A2, CYP2B6 and CYP3A4 may require a dose adjustment. Strong inducers of CYP1A2, CYP3A4 or CYP2C19: Consider dose increase of DIACOMIT. 7.1 Effect of DIACOMIT on Other Drugs CYP1A2, CYP2B6, CYP3A4, CYP2C8, CYP2C19, P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP) Substrates In vitro data show that stiripentol is both an inhibitor and inducer of CYP1A2, CYP2B6, and CYP3A4. Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT. Because of potential inhibition of enzyme/transporter activity, consider a reduction in dosage of substrates of CYP2C8, CYP2C19 (e.g., diazepam, clopidogrel), P-gp (e.g., carbamazepine), and BCRP (e.g., methotrexate, prazosin, glyburide), if adverse reactions are experienced when administered concomitantly with DIACOMIT. Clobazam Co-administration of DIACOMIT (which inhibits CYP 3A4 and 2C19) with clobazam results in increased plasma concentrations of clobazam (a substrate of CYP3A4) and norclobazam, the active metabolite of clobazam (a substrate of CYP2C19). This may increase the risk of clobazam-related adverse reactions. Consider a reduction in dosage of clobazam if adverse reactions are experienced when co-administered with DIACOMIT.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • No contraindications are listed.
  • Not studied in babies under 6 months or under 7 kg.
  • Not recommended with moderate or severe kidney or liver impairment.
  • PKU: the oral suspension contains phenylalanine.
  • Pregnancy: animal studies showed fetal harm. A pregnancy registry exists.
  • Breastfeeding: no human data. Discuss with your doctor.
  • Adults 65 and older: not studied.

Overdose

There are no human overdose data. In mice given very high doses, activity and breathing slowed. Treatment is supportive care. If you suspect an overdose, contact your regional Poison Control Center.

Half-Life and How Your Body Processes It

Stiripentol reaches peak blood levels in about 2 to 3 hours. It is 99% bound to proteins in the blood. It is mainly broken down by liver enzymes (CYP1A2, CYP2C19 and CYP3A4). Its half-life ranges from about 4.5 to 13 hours in adults, and it lengthens as body weight and dose increase. Exposure rises faster than the dose does.

Storage

Store in a dry place at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) . Store in original package to protect from light.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Stiripentol

From the licensed clinical database we use, rolled up per supplement, most serious first.

18 supplements and herbal products have documented interactions with Stiripentol in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 1Major
  • 8Moderate
  • 9Minor

See the other 10

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Stiripentol: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Stiripentol — the kind of thing our pharmacy team would talk through with you at the counter.

What is this medicine for?

Stiripentol (Diacomit) treats seizures from Dravet syndrome. It's used along with clobazam in children 6 months and older who weigh at least 7 kg. It isn't meant to be used alone.

How should we give it?

Give it by mouth with a meal, split into 2 or 3 doses a day as prescribed. Capsules go down whole with water. The powder is mixed in water and taken right away. If a dose is missed, take it as soon as you can, but skip it if the next dose is close.

What side effects should we expect?

Sleepiness and reduced appetite are the big ones. Weight loss, agitation, unsteadiness, nausea, tremor and trouble sleeping can also happen. Let your doctor know if sleepiness is heavy, as the clobazam dose may need adjusting.

Are there any tests needed?

Yes. Blood counts are checked before starting and then every 6 months, because stiripentol can lower certain blood cells. Your child's weight and growth will also be watched.

Can we stop it if it's not going well?

Please don't stop on your own. Stopping suddenly can make seizures more frequent and can trigger a long, dangerous seizure. Your doctor will lower the dose gradually.

What about alcohol, other medicines or pregnancy?

Alcohol and other drowsy-making medicines add to sleepiness. Stiripentol also changes levels of many other drugs, so always check before adding anything new. Animal studies showed harm to developing babies, so talk to your doctor if pregnancy is possible or you're breastfeeding.

Is stiripentol available over the counter?

No. Stiripentol is a prescription medicine: every stiripentol product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was stiripentol first available?

The earliest FDA record we hold for stiripentol is from 2018: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when stiripentol was first used.

What is the brand name of stiripentol?

Stiripentol is the generic name. Its brand name is Diacomit.

What is the generic name of Diacomit?

The generic name of Diacomit is stiripentol. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What strengths does stiripentol come in?

Stiripentol is listed in the FDA's National Drug Code Directory in these forms and strengths. Capsule (by mouth): 250 mg and 500 mg. Oral suspension (by mouth): 250 mg and 500 mg. A listing does not mean every pharmacy stocks every strength.

How much does stiripentol cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, state Medicaid programs paid an average of $35.76 to $72.20 per capsule of brand-name Diacomit across 2 strengths and $35.96 to $71.63 per mL of the oral suspension of brand-name Diacomit across 2 strengths over the four quarters through Q1 2026 (CMS's State Drug Utilization Data), before the rebates drug makers pay Medicaid. CMS's weekly pharmacy survey (NADAC) has no price for it, and Medicaid's figure is what a program paid, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a stiripentol shortage?

No. Stiripentol is not on the FDA's drug shortage list as of Nov 21, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the stiripentol prescribing information (package insert)?

The full FDA-approved prescribing information for stiripentol, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Biocodex, Inc.'s, revised Apr 27, 2026, and links to it on DailyMed.

Can you crush stiripentol?

Some forms of stiripentol are on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: Diacomit (capsule); stiripentol (capsule). They are listed for a reason such as irritation, a bad taste or a special formulation. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Stiripentol

Skip the scrolling. Ask in your own words and get an answer from Stiripentol’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Stiripentol’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Stiripentol on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Stiripentol Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Stiripentol Forms and Strengths (How It Comes)

Stiripentol comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Stiripentol inactive ingredients by manufacturer.

Capsule

By mouth
Brands Diacomit (the first brand, 2018)
How this form is used
What it may be used for
  • Diacomit is used for seizures associated with Dravet syndrome in patients taking clobazam who are 6 months or older and weigh 7 kg or more.
Important instructions
  • Diacomit capsules must be swallowed whole with a glass of water during a meal.
  • Diacomit capsules should not be broken or opened.
  • Diacomit capsules do not contain phenylalanine.
Available strengths 2 strengths
2 FDA-listed product records ⓘ

Oral suspension

By mouth
Brands Diacomit (the first brand, 2018)
How this form is used
What it may be used for
  • Diacomit is used for seizures associated with Dravet syndrome in patients taking clobazam who are 6 months or older and weigh 7 kg or more.
Important instructions
  • Diacomit powder for oral suspension is mixed in a glass of water and taken right away during a meal.
  • After drinking, add a small amount of water to the cup and drink it so no medicine is left behind.
  • Diacomit for oral suspension contains phenylalanine, which matters for people with PKU.
Available strengths 2 strengths
2 FDA-listed product records ⓘ

Stiripentol on the U.S. Market: Products, Makers and Brands

How Stiripentol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 4 Stiripentol product records with the FDA, mostly as capsule, oral suspension; the earliest marketing or approval year on record is 2018. The one brand name in the directory today is Diacomit; the rest are generics.

2
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
4
FDA-listed product records ⓘ
2018
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

How Widely Stiripentol Is Used (Medicaid Data)

How many Stiripentol prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

3,030
Medicaid prescriptions filled (Q1–Q4 2025)
$15.4M paid by Medicaid, before rebates

How commonly is Stiripentol prescribed? Of the 1,682 medications we measure, Stiripentol ranks #1,159 by Medicaid prescriptions — more than 31% of them.

Where Stiripentol ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Stiripentol product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 250 mg oral capsule is the most-dispensed Stiripentol product — about 32% of these Medicaid prescriptions.

stiripentol 250 MG Oral Capsule Most dispensed

968 Medicaid prescriptions (Q1–Q4 2025) 32% of Stiripentol prescriptions shown $4M paid by Medicaid, before rebates ≈ $4,153 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2054973

stiripentol 250 MG Powder for Oral Suspension

809 Medicaid prescriptions (Q1–Q4 2025) 27% of Stiripentol prescriptions shown $2.8M paid by Medicaid, before rebates ≈ $3,463 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2055015

stiripentol 500 MG Oral Capsule

678 Medicaid prescriptions (Q1–Q4 2025) 22% of Stiripentol prescriptions shown $4.6M paid by Medicaid, before rebates ≈ $6,758 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2054981

stiripentol 500 MG Powder for Oral Suspension

575 Medicaid prescriptions (Q1–Q4 2025) 19% of Stiripentol prescriptions shown $4M paid by Medicaid, before rebates ≈ $6,915 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2055011

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 4 of the 4 listed Stiripentol NDCs had Medicaid claims.

Compare Stiripentol Products

A representative set of FDA-listed product records for Stiripentol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Capsule
250 mg Oral Biocodex, Inc. NDA View NDC →
500 mg Oral Biocodex, Inc. NDA View NDC →
💊Oral suspension
250 mg Oral Biocodex, Inc. NDA View NDC →
500 mg Oral Biocodex, Inc. NDA View NDC →

Showing 4 of 4 products — FDA National Drug Code Directory. See every product, package size and price: browse all 4 Stiripentol NDCs →

Stiripentol Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Stiripentol recalls since July 2021.

✅No Stiripentol recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Stiripentol in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
4
Forms in current FDA listings
2 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Stiripentol RxCUI 2054968
  1. Dose form (SCDF) Oral Capsule RxCUI 2054972
    In current FDA listings
    Its 2 strengths (SCD)
  2. Dose form (SCDF) Powder for Oral Suspension RxCUI 2055010
    In current FDA listings
    Its 2 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Medicaid Pays for Stiripentol

CMS’s weekly pharmacy survey (NADAC) has no price for Stiripentol, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.

FormStrengthVersion What Medicaid paid
Capsule · Oral 250 mg Diacomit (brand) $35.76 per capsule NDC details & Medicaid use
Capsule · Oral 500 mg Diacomit (brand) $72.20 per capsule NDC details & Medicaid use
Oral suspension · Oral 250 mg Diacomit (brand) $35.96 per mL NDC details & Medicaid use
Oral suspension · Oral 500 mg Diacomit (brand) $71.63 per mL NDC details & Medicaid use
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.

Stiripentol Brand Names

Stiripentol has one brand name on record: Diacomit. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Diacomit the first brand, 2018

Who Makes Stiripentol: Manufacturers and Labelers

One company lists Stiripentol products with the FDA. By number of product records, the largest are Biocodex, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Biocodex, Inc. 4

Sources for This Stiripentol Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Apr 27, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Stiripentol.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
4
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Biocodex, Inc.
Linked label effective
Apr 27, 2026
Composite sections available
24
Linked SPL Set ID
58304ba8-9779-4658-811e-94ffe08c3f16
Linked SPL Document ID
7c968964-991e-4ec2-bc03-ef062b5bb0f9
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Biocodex, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →